#1 — Oral semaglutide
Evidence: ★★★★★ (FDA-approved, massive Phase 3 trials)
Mechanism: GLP-1 receptor agonist — appetite suppression, slowed gastric emptying
Fat loss: 15–20% total body weight in clinical trials
Muscle preservation: Poor — up to 40% of weight lost may be lean mass
Delivery: Oral daily tablet (no injection)
Cost: From $179/month compounded
The most proven fat loss compound available. If your primary goal is maximum weight reduction and you’re willing to accept some muscle loss, nothing beats semaglutide on evidence quality. The oral tablet form eliminates the needle barrier entirely. Best for: People with significant weight to lose (BMI 30+) who prioritize scale results.
#2 — AOD-9604
Evidence: ★★★☆☆ (Phase 2 trials completed, TGA-approved in Australia)
Mechanism: GH fragment — direct lipolysis, inhibits lipogenesis
Fat loss: Significant fat reduction in 300+ participant Phase 2 trial
Muscle preservation: Excellent — targets fat cells only, no effect on lean mass
Delivery: Oral capsule or injectable
Cost: Expected $150–300/month
The body recomposition peptide. AOD-9604 is the growth hormone fragment that specifically handles fat metabolism, stripped of the parts that affect insulin, blood sugar, and IGF-1. You lose fat without losing muscle, without appetite suppression, and without nausea. Best for: Lean individuals optimizing body composition. People who work out and want to cut fat while keeping (or building) muscle. The looksmaxxing crowd.
Pending FDA reclassification to Category 1.
#3 — Tirzepatide (oral)
Evidence: ★★★★★ (FDA-approved, SURMOUNT Phase 3 data)
Mechanism: Dual GLP-1/GIP agonist — stronger appetite suppression than semaglutide alone
Fat loss: Up to 22.5% body weight in clinical trials. Approaching bariatric surgery results.
Muscle preservation: Poor to moderate — better than semaglutide but still significant lean mass loss
Delivery: Oral tablet or injectable
Cost: From $279/month compounded
The nuclear option for weight loss. Tirzepatide outperformed semaglutide in head-to-head trials. If you need to lose a large amount of weight and semaglutide isn’t strong enough, this is the escalation. Same muscle loss caveat applies. Best for: Severe obesity, metabolic syndrome, cases where maximum weight loss is medically necessary.
#4 — CJC-1295 / Ipamorelin
Evidence: ★★★☆☆ (published pharmacokinetic and Phase 2 data)
Mechanism: GH secretagogue stack — boosts natural growth hormone production
Fat loss: Indirect — increased metabolic rate and improved body composition over 3–6 months
Muscle preservation: Excellent — GH actively promotes lean muscle retention
Delivery: Injectable only (subcutaneous)
Cost: $200–450/month
The long game. This stack doesn’t melt fat overnight. It optimizes your hormonal environment so that your body naturally shifts toward less fat and more muscle over months. Improved sleep, faster recovery, better skin, and gradual recomposition. Best for: People already in decent shape who want to optimize. Pairs exceptionally well with AOD-9604 for a dual-pathway approach.
Pending FDA reclassification (Ipamorelin expected Category 1; CJC-1295 uncertain).
#5 — Tesamorelin
Evidence: ★★★★☆ (FDA-approved for lipodystrophy)
Mechanism: Growth hormone releasing hormone — stimulates GH, specifically reduces visceral fat
Fat loss: Clinically proven reduction in visceral (belly) fat. Less effective for subcutaneous fat.
Muscle preservation: Good — GH-mediated lean mass maintenance
Delivery: Injectable only
Cost: $200–400/month
The belly fat specialist. Tesamorelin is the only GH peptide with full FDA approval (for a specific indication). Off-label use for visceral fat reduction is well-supported by clinical data. Best for: People specifically targeting abdominal/visceral fat that hasn’t responded to diet and exercise.
#6 — MOTS-c
Evidence: ★★☆☆☆ (strong preclinical, minimal human data)
Mechanism: Mitochondrial peptide — AMPK activation, exercise mimetic
Fat loss: Demonstrated in animal models. Human fat loss data not yet available.
Muscle preservation: Expected to be good based on mechanism
Delivery: Injectable only
Cost: $200–400/month estimated
The speculative bet with the best mechanism story. If MOTS-c delivers in humans what it delivers in mice, it’s a metabolic game-changer. But we’re still waiting for the human data. Best for: Biohackers and longevity-minded individuals willing to be early adopters. Not a primary fat loss tool.
Pending FDA reclassification.
The optimal stack for fat loss + muscle preservation
For people who want to lose fat WITHOUT losing muscle (the typical looksmaxxing goal):
Phase 1 (Months 1–3): AOD-9604 oral capsule daily. Direct fat metabolism without appetite suppression or muscle wasting. Pair with resistance training and adequate protein (1g/lb bodyweight).
Phase 2 (Months 3–6): Add CJC-1295/Ipamorelin injectable stack. GH optimization accelerates recomposition and improves recovery from training. AOD-9604 continues.
Alternative path for aggressive weight loss: Oral semaglutide for Months 1–3, then transition to AOD-9604 + CJC-1295/Ipamorelin for Months 4–6 to preserve and rebuild lean mass.
All protocols should be designed by a licensed physician based on your bloodwork, health history, and specific goals.